Llgl2 - LLGL scribble cell polarity complex component 2 Gene
Also Known as RGD1560307
Species: Rattus norvegicus
Summary
Predicted to enable GTPase activator activity; PDZ domain binding activity; and Myosin II binding activity. Predicted to be involved in several processes, including Cytoskeleton organization; leucine transport; and regulation of Notch signaling pathway. Predicted to act upstream of or within establishment or maintenance of polarity of embryonic epithelium; labyrinthine layer development; and post-embryonic development. Predicted to be located in cytosol and intracellular membrane-bounded organelle. Predicted to be active in cortical actin Cytoskeleton and plasma membrane. Orthologous to human LLGL2 (LLGL scribble cell polarity complex component 2). [provided by Alliance of Genome Resources, Apr 2022]
Llgl2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001127549.1 | NP_001121021.1 | LLGL scribble cell polarity complex component 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
LLGL scribble cell polarity complex component 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS07701 | LLGL2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22611 | Llgl2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS29126 | Llgl2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service